No Image Provided

Heydoc

VC Funding

Series A Angel-backed

Healthcare & Biotech Software & SaaS Published 27 September 2021

Summary

In a significant market movement during September 2021, Heydoc was the subject of a vc funding. The transaction achieved a gross valuation of £6,060,745. Leading the round was Triple Point Ventures, InHealth Ventures, Hambro Perks, Smedvig Capital.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Triple Point Ventures

Lead Investor / Acquirer

InHealth Ventures

Lead Investor / Acquirer

Hambro Perks

Lead Investor / Acquirer

Smedvig Capital

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech / Software & SaaS

Series A prioritised

VC Funding

MYNDUP

£4,400,000

Nov 2022

VC Funding

Meddbase

£2,250,000

Oct 2021

VC Funding

Visionable

£500,000

Nov 2020

VC Funding

Visionable

£5,941,848

Jun 2020

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.